Target intelligence / Profile preview

Novel Sp100-like protein pseudogene

Molecular classification
Pseudogene
01

Overview

Novel Sp100-like protein pseudogene (ENSG00000283202) is classified as a pseudogene, identified by loss of protein-coding potential due to disabling mutations. While the parental SP100 gene encodes a nuclear antigen involved in immune response, transcriptional regulation, and chromatin dynamics, the pseudogene lacks protein function and is not considered a drug target. Pseudogenes can exert regulatory functions at the RNA level, but there is currently no evidence of any established function, aliases, disease association, drug interactions, or therapeutic relevance for this particular pseudogene. The presence of the "like" designation indicates sequence similarity to SP100 but without a known biological or pharmacological role.

02

Biological functions

Other (pseudogenes are mostly nonfunctional at the protein level but can sometimes regulate gene networks by influencing their parent gene's expression)
03

Disease associations

Other (pseudogenes may have regulatory effects that can impact disease, but no direct link is established for this specific pseudogene)

Beyond the preview

Go deeper on Novel Sp100-like protein pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel Sp100-like protein pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call